Skip Navigation



ToxSci Advance Access published online on October 8, 2008

Toxicological Sciences, doi:10.1093/toxsci/kfn217
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
107/1/1    most recent
kfn217v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Taylor, R. T.
Right arrow Articles by Hankinson, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taylor, R. T.
Right arrow Articles by Hankinson, O.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the Society of Toxicology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

Roles of Coactivator Proteins in Dioxin Induction of CYP1A1 and CYP1B1 in Human Breast Cancer Cells

Robert T. Taylor*, Feng Wang, Erin L. Hsu+ and Oliver Hankinson

Molecular Toxicology Program (R.T.T., E.L.H., O.H.), Department of Pathology and Laboratory Medicine, and the Jonsson Comprehensive Cancer Center (R.T.T., F.W., E.L.H., O.H.) University of California, Los Angeles, CA 90095

Oliver Hankinson, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, Center for the Health Sciences, UCLA, Box 951732, Los Angeles, CA 90095-1732, Tel: (310) 825-2936, Fax: (310) 794-9272, ohank{at}mednet.ucla.edu

Received September 10, 2008; revision received October 2, 2008; accepted October 2, 2008


   Abstract

CYP1A1 and CYP1B1 are inducible by 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin) in the human breast cancer cell line, MCF-7. Since CYP1A1 was inducible to a much greater degree than CYP1B1, we hypothesized that there may be differences in coactivator recruitment to the promoter and/or enhancer regions of these genes. . Dioxin treatment lead to recruitment of the aryl hydrocarbon receptor (AHR) to the enhancer regions, but not to the proximal promoter regions of both the CYP1A1 and CYP1B1 genes. On the other hand, dioxin treatment facilitated recruitment of RNA polymerase II (pol II) to the promoters, but not the enhancer regions. Dioxin treatment also elicited recruitment of the transcriptional coactivators, Steriod Receptor Coactivators 1 and 2 (SRC-1 and SRC-2) and p300, which possess intrinsic histone acetyltranferase activities, to both genes, whereas Brahma SWI2/related gene 1 (BRG-1), a subunit of nucleosomal remodeling factors, was recruited more robustly to CYP1A1 relative to CYP1B1. SiRNA-mediated knock-down of p300 and SRC-2 adversely affected dioxin induction of both genes, whereas knock-down of Brahma/BRG-1 reduced CYP1A1 induction but had little, if any, effect on CYP1B1 induction. These results suggest that nucleosomal remodeling is less significant for dioxin-mediated induction of CYP1B1 than that of CYP1A1 and may be related to the more modest inducibility of the former. Interestingly, simultaneous knock-down of SRC-2 and Brahma/BRG-1 had no greater effect on CYP1A1 induction than knock-down of each coactivator individually, while simultaneous knock-down of p300 and Brahma/BRG-1 had a much greater effect than knock-down of each individual gene, suggesting that the recruitment of SRC-2 to CYP1A1 depends upon Brahma/BRG-1, while the recruitments of p300 and Brahma/BRG-1 are independent of each other. These observations provide novel insights into the functional roles of the endogenous coactivators in dioxin induction of the human CYP1A1 and CYP1B1 genes in their natural chromosomal configurations.

Key Words: CYP1A1; CYP1B1; Aryl Hydrocarbon Receptor; transcription; coactivator.


* Current address: CellzDirect Invitrogen Corporation,1624 Headway Circle, Austin, TX 78754. Rob.Taylor{at}invitrogen.com

+ Current address: Northwestern University Feinberg School of Medicine, 303 E. Chicago Ave. Ward 10-258, Chicago, IL 60611. e-hsu{at}northwestern.edu, (FWang{at}mednet.ucla.edu)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
S. R. Beedanagari, I. Bebenek, P. Bui, and O. Hankinson
Resveratrol Inhibits Dioxin-Induced Expression of Human CYP1A1 and CYP1B1 by Inhibiting Recruitment of the Aryl Hydrocarbon Receptor Complex and RNA Polymerase II to the Regulatory Regions of the Corresponding Genes
Toxicol. Sci., July 1, 2009; 110(1): 61 - 67.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
O. Hankinson
Repression of Aryl Hydrocarbon Receptor Transcriptional Activity by Epidermal Growth Factor
Mol. Interv., June 1, 2009; 9(3): 116 - 118.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. H. Sutter, H. Yin, Y. Li, J. S. Mammen, S. Bodreddigari, G. Stevens, J. A. Cole, and T. R. Sutter
EGF receptor signaling blocks aryl hydrocarbon receptor-mediated transcription and cell differentiation in human epidermal keratinocytes
PNAS, March 17, 2009; 106(11): 4266 - 4271.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.